Crizotinib in MET deregulated...

Clinical Cancer Research 2019 / 08

Crizotinib in MET deregulated or ROS1 rearranged pretreated non-small-cell lung cancer (METROS): a phase II, prospective, multicentre, two-arms trial

Landi, Lorenza, Chiari, Rita, Tiseo, Marcello, D'Incà, Federica, Dazzi, Claudio, Chella, Antonio, Delmonte, Angelo, Bonanno, Laura, Giannarelli, Diana, Cortinovis, Diego Luigi, De Marinis, Filippo, Bo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-0994
Date:
August, 2019
File:
PDF, 748 KB
2019
Conversion to is in progress
Conversion to is failed